Sp554
MANAGEMENT OF GASTRIC INTESTINAL METAPLASIA AND ATROPHIC GASTRITIS
Date
May 7, 2023
Explore related products in the following collection:
Society: AGA
Review updates in management of common GI disorders including irritable bowel syndrome, use of cannabis and functional dyspepsia.
Review updates in management of common GI disorders including irritable bowel syndrome, use of cannabis and functional dyspepsia.
Presenter
University of California San Diego
Tracks
Related Products
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
STANDARD AND ALTERNATIVE THERAPIES FOR <i>H.PYLORI</i> INFECTION IN 2023
40 years after the organism was first recognized and grown in culture, Helicobacter pylori infections are still commonly encountered in practice,. This symposium will focus on several areas that remain unresolved to this day - including how best to manage H…
PANEL DISCUSSION
Review updates in management of common GI disorders including irritable bowel syndrome, use of cannabis and functional dyspepsia…
